Riess, H <br/><br/>
Thromboxane receptor blockade versus cyclooxigenase inhibition: antiplatelet effects in patients.  [electronic resource] 

 -  Thrombosis research  Apr 1986 
 - 235-45 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0049-3848 
<br/><br/><label>Standard No.: </label>10.1016/0049-3848(86)90299-9  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid<br/>Angioplasty, Balloon<br/>Arteriosclerosis--therapy<br/>Aspirin--therapeutic use<br/>Bleeding Time<br/>Blood Platelets--drug effects<br/>Clinical Trials as Topic<br/>Collagen--pharmacology<br/>Cyclooxygenase Inhibitors<br/>Female<br/>Fibrinolytic Agents--therapeutic use<br/>Humans<br/>Male<br/>Middle Aged<br/>Platelet Aggregation--drug effects<br/>Prostaglandin Endoperoxides, Synthetic--pharmacology<br/>Receptors, Cell Surface--drug effects<br/>Receptors, Prostaglandin--drug effects<br/>Receptors, Thromboxane<br/>Sulfonamides--therapeutic use<br/>Thromboxane B2--blood<br/>Thromboxanes--blood